Report an error

Spotted something inaccurate in “Oral PCSK9 Inhibitors Match Injectable Efficacy With 55–60% LDL Reduction”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.